PI
HAE icon

PFS Investments’s Haemonetics HAE Stock Holding History

PFS Investments’s Portfolio HAE Stock Details HAE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q2 		$381K Buy
4,470
+474
+12% +$40.1K 0.01% 421
2023
Q1 		$329K Buy
+3,996
New +$323K 0.01% 419

Other funds holding HAE

Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Neuberger Berman Group
Neuberger Berman Group New York $150B AUM 40.08% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
Schroder Investment Management Group
Schroder Investment Management Group London, United Kingdom $141B AUM 34.18% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

PFS Investments's HAE Position: Q2 2023 in Review

PFS Investments increased its Haemonetics (HAE) stake by 12% in Q2 2023, buying an estimated $40.1K and bringing the position to 4,470 shares worth $381K. The position accounts for 0.01% of the portfolio, ranked #421.

PFS Investments first reported a position in HAE in Q1 2023 and has held it in 2 quarters since. 294 funds tracked by Wall St. Rank hold HAE as of Q2 2023.

  • PFS Investments held 4,470 shares of Haemonetics worth $381K as of Q2 2023.
  • PFS Investments bought 474 Haemonetics shares in Q2 2023, an estimated $40.1K.
  • Haemonetics made up 0.01% of PFS Investments's portfolio in Q2 2023, its #421 holding.
  • PFS Investments first reported a position in Haemonetics in Q1 2023 and has held it in 2 quarters since.
  • 294 funds tracked by Wall St. Rank held Haemonetics as of Q2 2023.

Based on PFS Investments's 13F filing for Q2 2023, filed 14 Aug 2023.